Information for Shareholders and Investors

Latest news and press releases

  • 22 sep, 2017

    FDA approves Grifols Prolastin®-C Liquid [alpha-1 proteinase inhibitor, liquid] for the treatment of alpha-1 antitrypsin deficiency Download (159.2 Kb)

  • 28 jul, 2017

    Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions Download (289.2 Kb)

  • 05 jul, 2017

    Grifols opens new lines of research with the acquisition of a 44% stake in GigaGen Download (400.1 Kb)